CR10116A - Enzimas para estres inmunólogico reducido - Google Patents

Enzimas para estres inmunólogico reducido

Info

Publication number
CR10116A
CR10116A CR10116A CR10116A CR10116A CR 10116 A CR10116 A CR 10116A CR 10116 A CR10116 A CR 10116A CR 10116 A CR10116 A CR 10116A CR 10116 A CR10116 A CR 10116A
Authority
CR
Costa Rica
Prior art keywords
animal
enzymes
immunological stress
reduced immunological
level
Prior art date
Application number
CR10116A
Other languages
English (en)
Inventor
M Anderson David
Hsiao Humg-Yu
Liu Lin
Original Assignee
Lilly Co Eli
Memory Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli, Memory Pharm Corp filed Critical Lilly Co Eli
Publication of CR10116A publication Critical patent/CR10116A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/244—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/2488—Mannanases
    • C12N9/2494—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01014—Chitinase (3.2.1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01078—Mannan endo-1,4-beta-mannosidase (3.2.1.78), i.e. endo-beta-mannanase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere composiciones adecuadas para administración oral a un mamífero que comprende, al menos una enzima que reduce el estrés inmune en una cantidad efectiva para reducir el nivel de proteína de fase aguda positiva en un animal, incrementar el nivel de proteína de fase aguda negativa en un animal, y/o mejorar el desempeño de crecimiento del animal, como son métodos para usar tales composiciones.
CR10116A 2005-12-15 2008-06-26 Enzimas para estres inmunólogico reducido CR10116A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75033905P 2005-12-15 2005-12-15

Publications (1)

Publication Number Publication Date
CR10116A true CR10116A (es) 2008-10-28

Family

ID=38218427

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10116A CR10116A (es) 2005-12-15 2008-06-26 Enzimas para estres inmunólogico reducido

Country Status (35)

Country Link
US (5) US7914782B2 (es)
EP (2) EP1973561B1 (es)
JP (1) JP5189989B2 (es)
KR (2) KR101399205B1 (es)
CN (3) CN102293323A (es)
AR (1) AR057247A1 (es)
AT (1) ATE497779T1 (es)
AU (1) AU2006329927B2 (es)
BR (1) BRPI0620155B1 (es)
CA (1) CA2633066C (es)
CL (1) CL2011000941A1 (es)
CR (1) CR10116A (es)
DE (1) DE602006020074D1 (es)
DK (1) DK1973561T3 (es)
EC (1) ECSP088578A (es)
ES (1) ES2361819T3 (es)
GT (1) GT200600512A (es)
HN (1) HN2008000906A (es)
HR (1) HRP20080319B1 (es)
IL (2) IL192088A (es)
IN (1) IN2008DE06112A (es)
MX (1) MX284326B (es)
MY (1) MY145870A (es)
NO (1) NO340818B1 (es)
NZ (1) NZ569186A (es)
PE (1) PE20070840A1 (es)
PL (1) PL1973561T3 (es)
PT (1) PT1973561E (es)
RU (1) RU2465005C2 (es)
SI (1) SI1973561T1 (es)
SV (1) SV2008002942A (es)
TW (2) TWI402039B (es)
UA (1) UA95266C2 (es)
WO (1) WO2007075343A2 (es)
ZA (1) ZA200805780B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20080319B1 (hr) * 2005-12-15 2015-11-20 Eli Lilly And Co. Enzimi za smanjenje imunološkog stresa
JP6046168B2 (ja) * 2012-02-16 2016-12-14 イーライ リリー アンド カンパニー 動物排泄物の環境影響を減少させるための方法および組成物
EP3030093B1 (en) * 2013-07-26 2017-09-06 Novozymes A/S POLYPEPTIDES HAVING alpha-L-GALACTOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
DK3119901T3 (da) * 2014-03-21 2021-07-26 Dsm Ip Assets Bv Fremgangsmåde til behanlding af gærcellevægge med en laminaripentaose-producerende beta-1,3-glucanase
CN106771257A (zh) * 2017-01-24 2017-05-31 北京美正生物科技有限公司 一种检测血清淀粉样蛋白a的酶联免疫吸附试剂盒及其制备方法和用途
CN107156522A (zh) * 2017-06-23 2017-09-15 都匀市山郎科技养殖有限公司 一种鸡饲料
BE1030865B1 (nl) * 2022-09-12 2024-04-09 Nu3Guts Bv Voederadditief voor het verbeteren van de darmgezondheid en/of de verteerbaarheid van voeder in vee
WO2025099136A2 (en) * 2023-11-10 2025-05-15 Kerry Group Services International Limited Nucleases in animal feed

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201949A (ja) * 1982-05-17 1983-11-25 Kyodo Shiryo Kk 家畜用配合飼料
US5372939A (en) * 1991-03-21 1994-12-13 The United States Of America As Represented By The United States Department Of Energy Combined enzyme mediated fermentation of cellulous and xylose to ethanol by Schizosaccharoyces pombe, cellulase, β-glucosidase, and xylose isomerase
JP2942384B2 (ja) * 1991-06-07 1999-08-30 株式会社ヤクルト本社 飼料効率改善添加剤
GB2261877A (en) * 1991-11-21 1993-06-02 Kyowa Hakko Kogyo Kk Animal feed additive comprising enzyme and amino acid
WO1995005455A1 (en) * 1993-08-13 1995-02-23 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
US5861271A (en) 1993-12-17 1999-01-19 Fowler; Timothy Cellulase enzymes and systems for their expressions
CN1064817C (zh) 1994-04-22 2001-04-25 诺沃挪第克公司 一种提高植物蛋白溶解性的方法
GB9416841D0 (en) * 1994-08-19 1994-10-12 Finnfeeds Int Ltd An enzyme feed additive and animal feed including it
NL1003096C2 (nl) 1995-05-15 1996-11-19 Gist Brocades Bv Application of phospholipases in animal feed.
JP2001057852A (ja) * 1995-06-14 2001-03-06 Showa Denko Kk 耐熱酵素含有飼料用組成物
US5807694A (en) * 1995-09-07 1998-09-15 Economic Innovation And Technology Council, University Of Manitoba Detection of salmonella enteritidis and other pathogenic microorganisms and monoclonal antibody useful therefor
WO1997016982A1 (en) * 1995-11-06 1997-05-15 Novo Nordisk A/S Animal feed additives
EP0904359A1 (en) 1996-04-12 1999-03-31 Novo Nordisk A/S AN ENZYME WITH $g(b)-1,3-GLUCANASE ACTIVITY
CN1092495C (zh) 1996-05-03 2002-10-16 开姆根有限公司 半纤维素酶在低热焓饲料中的应用
US6162473A (en) 1996-05-03 2000-12-19 Chemgen Corporation Hemicellulase use in feeds with low caloric content
US20020164751A1 (en) * 1996-06-19 2002-11-07 Short Jay M. Enzymes having thermostable phosphatase activity and methods of use thereof
GB9623539D0 (en) * 1996-11-12 1997-01-08 Biotal Ltd Enzymes and their use
GB2327345B (en) * 1997-07-18 1999-06-23 Finnfeeds Int Ltd Use of an enzyme for manufacturing an agent for controlling bacterial infection
US6022566A (en) * 1997-12-02 2000-02-08 Balchem Corporation Method for increasing the feed intake, feed efficiency, daily gain and/or carcass grade in ruminants
EP0976838A1 (en) * 1998-05-06 2000-02-02 Rhone-Poulenc Nutrition Animale Enzymes mixture
US6331426B1 (en) * 1999-02-11 2001-12-18 Novozymes A/S Bacterial galactanases and use thereof
US6213930B1 (en) 1999-03-15 2001-04-10 Wisconsin Alumni Research Foundation Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency
US6500658B1 (en) * 1999-08-17 2002-12-31 Novozymes, A/S Xyloglucanase from Malbranchea
UA78486C2 (uk) * 1999-12-10 2007-04-10 Хемджен Корпорейшн Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
GB0010748D0 (en) 2000-05-05 2000-06-28 Brown Paul D Tricep exercise horse (fold up and portable)
AU2001269923A1 (en) * 2000-06-19 2002-01-02 Genzyme Corporation Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
GB2371013B (en) 2001-01-16 2004-06-09 Terry John Claydon Copying apparatus
WO2002057408A2 (en) * 2001-01-17 2002-07-25 Ramot At Tel Aviv University Ltd. Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
DE10105306A1 (de) * 2001-02-02 2002-08-22 Nutrinova Gmbh Futtermittel für die Nutztieraufzucht enthaltend Sorbinsäure und Enzyme
DE10105347A1 (de) * 2001-02-05 2002-08-22 Nutrinova Gmbh Sorbinsäurepräparat enthaltend Probiotika als Futtermittelzusatz in der Nutztieraufzucht
IE20011100A1 (en) * 2001-12-21 2003-07-09 Vsl Pharma Ltd Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
CN1622761A (zh) * 2002-01-25 2005-06-01 Dsmip资产公司 热稳定酶组合物
AU2003304239A1 (en) * 2002-11-13 2005-01-13 Yvonne J. Rosenberg A pretreatment or post exposure treatment for exposure to a toxic substance by pulmonary delivery (inhaler) of a bioscavenger
EP1572230B1 (en) * 2002-12-12 2010-09-08 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
US20110142817A1 (en) * 2004-02-04 2011-06-16 Pharmaaware Sepsis B.V. Means and method for treating and/or preventing necrotizing enterocolitis
JP4999467B2 (ja) * 2004-02-04 2012-08-15 ファルマアウェア セプシス ビー．ブイ． 粘膜関門に存在するｌｐｓを解毒するためのアルカリホスファターゼの使用
WO2005094874A1 (en) * 2004-04-01 2005-10-13 Zymenex A/S Medical use of alpha-mannosidase
JP4977124B2 (ja) * 2005-03-25 2012-07-18 ウニベルズィタイト・ヘント フラボノイド類の酵素的脱メチル化
CN1699576A (zh) * 2005-06-30 2005-11-23 江南大学 一种内切β－1,3葡聚糖酶基因及其克隆方法
WO2007032818A2 (en) * 2005-09-12 2007-03-22 Zoltan Laboratories Llc Compounds and compositions to control abnormal cell growth
HRP20080319B1 (hr) * 2005-12-15 2015-11-20 Eli Lilly And Co. Enzimi za smanjenje imunološkog stresa
WO2009106368A1 (en) * 2008-02-29 2009-09-03 Gelato Corporation N.V. Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases

Also Published As

Publication number Publication date
KR101454032B1 (ko) 2014-10-27
ES2361819T3 (es) 2011-06-22
CN101374544B (zh) 2016-05-18
EP1973561A2 (en) 2008-10-01
ECSP088578A (es) 2008-10-31
AU2006329927A1 (en) 2007-07-05
UA95266C2 (uk) 2011-07-25
EP2263685A3 (en) 2011-04-06
EP1973561B1 (en) 2011-02-09
NO340818B1 (no) 2017-06-26
WO2007075343A3 (en) 2007-10-04
NZ569186A (en) 2011-09-30
JP2009519712A (ja) 2009-05-21
PL1973561T3 (pl) 2011-08-31
IL192088A (en) 2013-07-31
ATE497779T1 (de) 2011-02-15
MY145870A (en) 2012-05-15
US20110177195A1 (en) 2011-07-21
BRPI0620155B1 (pt) 2015-07-21
CN105831428A (zh) 2016-08-10
TW200731932A (en) 2007-09-01
PT1973561E (pt) 2011-05-12
IN2008DE06112A (es) 2008-09-26
US7914782B2 (en) 2011-03-29
GT200600512A (es) 2007-06-28
SI1973561T1 (sl) 2011-07-29
AU2006329927B2 (en) 2011-09-29
PE20070840A1 (es) 2007-08-25
US20070141041A1 (en) 2007-06-21
IL192088A0 (en) 2009-02-11
ZA200805780B (en) 2009-03-25
KR20130082514A (ko) 2013-07-19
HRP20080319B1 (hr) 2015-11-20
DK1973561T3 (da) 2011-05-23
EP2263685A2 (en) 2010-12-22
KR101399205B1 (ko) 2014-05-27
MX284326B (en) 2011-03-01
BRPI0620155A2 (pt) 2011-11-01
DE602006020074D1 (de) 2011-03-24
TWI619506B (zh) 2018-04-01
CA2633066C (en) 2015-01-20
CA2633066A1 (en) 2007-07-05
US20110171344A1 (en) 2011-07-14
US8778648B2 (en) 2014-07-15
JP5189989B2 (ja) 2013-04-24
RU2008128583A (ru) 2010-01-20
HRP20080319A2 (hr) 2008-12-31
AR057247A1 (es) 2007-11-21
KR20080081972A (ko) 2008-09-10
TWI402039B (zh) 2013-07-21
CN102293323A (zh) 2011-12-28
SV2008002942A (es) 2008-12-03
US20110171345A1 (en) 2011-07-14
CN105831428B (zh) 2020-12-01
HN2008000906A (es) 2011-07-12
MX2008007735A (en) 2008-08-27
CL2011000941A1 (es) 2014-08-08
IL227318A (en) 2016-11-30
RU2465005C2 (ru) 2012-10-27
TW201336425A (zh) 2013-09-16
WO2007075343A2 (en) 2007-07-05
CN101374544A (zh) 2009-02-25
NO20083035L (no) 2008-09-11
US20170156371A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
CR10116A (es) Enzimas para estres inmunólogico reducido
BR112014014834A2 (pt) composições para cuidado oral
UY31789A1 (es) Composiciones de insulina de super rápida actuación
CY1118601T1 (el) Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων
AR118760A2 (es) Coaglomerados de manitol y de almidón granular comprimibles y de libre fluidez
EA201201298A1 (ru) Фунгицидные композиции, содержащие фосфорастворимый микроорганизм и фунгицидно активное соединение
MX337028B (es) Eliminacion de serina proteasas por tratamiento con dioxido de silicona finamente dividido.
EA201890942A1 (ru) Мультивалентные вакцины с синтетическими наноносителями
AR076941A1 (es) Cepa de bacillus para una mayor produccion de proteina
MX2013001527A (es) Nuevas vacunas adyuvantes en base a adyuvantes de orientacion para anticuerpos directamente hacia celulas presentadoras de antigenos.
NI201200174A (es) Derivados de carbamato de hexafluoroisopropilo, su preparación y su aplicación en terapéutica.
SG10201405377XA (en) Compositions and methods for antibodies targeting complement protein c5
PE20140190A1 (es) Moduladores de proteinas notum y metodos de uso
EA201391489A1 (ru) Композиции со сниженной вязкостью
EA201290199A1 (ru) Способы и композиции для получения сквалена с применением дрожжей
MX373157B (es) Metodos de extincion mejorados para la inactivacion de patogenos en globulos rojos.
MX2012005782A (es) Procedimientos, composiciones y kits de liofilizacion.
AR071917A1 (es) Vacunas contra la coccidiosis
WO2009137778A3 (en) Methods and compositions for genetically engineering clostridia species
EA201490945A1 (ru) Набор, содержащий заменитель сыворотки и лабильные факторы
AR054525A1 (es) Composiciones y metodos para eltratamiento de sintomas relacionados con el ciclo
BR112014000542A2 (pt) composições de peroxidase eosinofílica e métodos de uso das mesmas
AR046123A1 (es) Aislamiento de celulas simil-celulas madre, uso de las mismas
MX385179B (es) Una composicion no nematicida y uso de los mismos.
SG148171A1 (en) Methods of proliferating stem cells